Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
JPMorgan: Optimistic About Stripe's AI and Payment "Dual Revolution," with Potential Market Opportunities Exceeding $350 billions

JPMorgan: Optimistic About Stripe's AI and Payment "Dual Revolution," with Potential Market Opportunities Exceeding $350 billions

金色财经金色财经2025/10/23 22:12
Show original

Jinse Finance reported that JPMorgan analysts stated that payment giant Stripe is leveraging AI-driven commerce and digital asset infrastructure to lay out a "dual revolution," potentially opening up market opportunities exceeding $350 billion before 2030. Stripe achieved profitability last year, with annual payment processing volume surpassing $1.4 trillion. Through the acquisitions of Bridge and Privy, as well as the launch of the Tempo blockchain, the company is deeply engaged in the stablecoin and crypto wallet business, laying the foundation for the integration of global payments for AI agent commerce and programmable money. However, analysts also cautioned that corporate expansion, business spin-offs, and regulatory risks still exist, especially regarding US stablecoin regulation and the European MiCA rules.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The 160 Threshold Under Threat Again! Yen Nears "Intervention Red Line," Tokyo May Spend Money Again to Rescue the Currency

The Japanese yen is approaching the 1 USD = 160 JPY level. Atsushi Mimura commented that the movement is "too fast." The US-Japan interest rate gap may widen further, and Japanese officials have hinted at being ready to intervene again.

智通财经•2026/11/12 02:26

Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race

Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.

智通财经•2026/11/12 01:07